Biotech Stocks Facing FDA Decision In December 2024
The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step ...
FiercePharma5h
FDA considers 'regulatory action' for bluebird's Skysona after blood cancer reports
The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s gene therapy Skysona ...
STAT2h
Pharmalittle: We’re reading about a former Trump FDA chief criticizing RFK Jr., a radiopharmaceuticals talent shortage, and more
Former FDA commissioner Scott Gottlieb is raising concerns with Senate Republicans about the president-elect’s selection of ...
Targeted Oncology1h
November 2024 FDA Updates: Key Developments in Oncology
The FDA granted approval to nilotinib (Danziten) on November 14, 2024, for the treatment of adult patients with newly ...
Editorial: A small but important win for FDA under fire
Given how the U.S. Supreme Court’s conservative majority is better known for limiting the authority of federal regulatory ...
Pie Recall Update As FDA Sets Most Serious Risk Level
Products sold in the Northwest have been given the highest risk status, but so far no illnesses have been reported.
BioPharma Dive1h
Applied’s rare disease drug rejected by FDA
Executives at Applied Therapeutics told analysts they were surprised by the agency’s refusal to approve the company’s treatment for classic galactosemia.
FDA grants breakthrough device designation to deepull’s BSI test
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...